Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P. Piccini, Veronika Eder, Jonas Oldgren et al.|The Lancet|2022Cited by 310
Heme Oxygenase Activity Modulates Vascular Endothelial Growth Factor Synthesis in Vascular Smooth Muscle CellsJózef Dulak, Roberto Motterlini, Alicja Józkowicz et al.|Antioxidants and Redox Signaling|2002Cited by 182